Influence of the genotype at rs10490924
(A69S) in age-related maculopathy susceptibility 2 on the time course of the logMAR baseline best corrected visual acuity
(BCVA) value was evaluated in all polypoidal choroidal vasculopathy patients treated by photodynamic therapy (PDT). All values
are presented as means±standard error of the mean (SEM). The GG and GT genotypes show significant improvements in their mean
BCVA at 3, 6, and 12 months (p<0.05, ** p<0.01, *** p<0.001).